SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-223254
Filing Date
2011-08-15
Accepted
2011-08-15 16:40:57
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 716502
2 RULE 13A-14(A)/15D-14A(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6946
3 RULE 13A-14(A)/15D-14A(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 7146
4 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3390
5 SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3578
  Complete submission text file 0001193125-11-223254.txt   3186114

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isco-20110630.xml EX-101.INS 489904
7 XBRL TAXONOMY EXTENSION SCHEMA isco-20110630.xsd EX-101.SCH 24852
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20110630_cal.xml EX-101.CAL 40037
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20110630_def.xml EX-101.DEF 27755
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20110630_lab.xml EX-101.LAB 180715
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20110630_pre.xml EX-101.PRE 118799
Mailing Address 2595 JASON COURT OCEANSIDE CA 92056
Business Address 2595 JASON COURT OCEANSIDE CA 92056 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 111037017
SIC: 2834 Pharmaceutical Preparations